TD Cowen Maintains Outperform on Biohaven, Raises Price Target to $55
Portfolio Pulse from Benzinga Newsdesk
TD Cowen analyst Tyler Van Buren has maintained an Outperform rating on Biohaven (NYSE:BHVN) and increased the price target from $35 to $55.
March 01, 2024 | 1:39 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Biohaven's Outperform rating is maintained by TD Cowen, with the price target raised from $35 to $55.
The increase in price target by a reputable analyst like Tyler Van Buren from TD Cowen is a strong positive signal for Biohaven. It suggests confidence in the company's future performance and potential for growth, likely leading to increased investor interest and potentially a rise in stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100